Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID, says Lancet
India | Nov 12, 2021, 09:12 AM ISTRecently, WHO granted emergency use listing to Covaxin enabling countries to expedite their regulatory approval to import and administer doses.